{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:24:51Z","timestamp":1789989891871,"version":"4.0.1"},"reference-count":42,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.00605","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T07:09:17Z","timestamp":1491376157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP)"],"prefix":"10.3389","volume":"08","author":[{"given":"Fangjun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/315186","article-title":"Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents.","volume":"181","author":"Angus","year":"2000","journal-title":"J. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.1074\/jbc.270.19.11391","article-title":"Biochemical and molecular characterization of nucleoside triphosphate hydrolase isozymes from the parasitic protozoan Toxoplasma gondii.","volume":"270","author":"Asai","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/S0021-9258(18)32295-6","article-title":"A potent nucleoside triphosphate hydrolase from the parasitic protozoan Toxoplasma gondii. Purification, some properties, and activation by thiol compounds.","volume":"258","author":"Asai","year":"1983","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nbt0698-562","article-title":"Enhancing immune responses using suicidal DNA vaccines.","volume":"16","author":"Berglund","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis.","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/fpd.2010.0795","article-title":"Toxoplasma in animals, food, and humans: an old parasite of new concern.","volume":"8","author":"Cenci-Goga","year":"2011","journal-title":"Foodborne Pathog. Dis."},{"key":"B8","author":"Dubey","year":"2010","journal-title":"Toxoplasmosis of Animals and Humans"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.4049\/jimmunol.165.5.2850","article-title":"Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.","volume":"165","author":"Dupuis","year":"2000","journal-title":"J. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/319857","article-title":"Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.","volume":"183","author":"Fleeton","year":"2001","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J. Immunother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines.","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"e52","key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM\u00a9 vaccine against H7N9 influenza is immunogenic in mice.","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids.","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/nar\/23.9.1495","article-title":"A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo.","volume":"23","author":"Johanning","year":"1995","journal-title":"Nucleic Acids Res."},{"issue":"e29732","key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029732","article-title":"Intradermal electroporation of naked replicon RNA elicits strong immune responses.","volume":"7","author":"Johansson","year":"2012","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/IAI.70.1.185-191.2002","article-title":"Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.","volume":"70","author":"Johnson","year":"2002","journal-title":"Infect. Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1016\/j.vaccine.2010.01.031","article-title":"Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells.","volume":"28","author":"Jongert","year":"2010","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities.","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.","volume":"164","author":"Kang","year":"2000","journal-title":"J. Immunol."},{"key":"B21","first-page":"543","article-title":"Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors.","volume":"246","author":"Karlsson","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine.","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1017\/S0031182015001985","article-title":"Induction of Autophagy interferes the tachyzoite to bradyzoite transformation of Toxoplasma gondii.","volume":"143","author":"Li","year":"2016","journal-title":"Parasitology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4161\/hv.21006","article-title":"Vaccines against Toxoplasma gondii: status, challenges and future directions.","volume":"8","author":"Liu","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"issue":"77","key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-10-77","article-title":"Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis.","volume":"10","author":"Lorenzi","year":"2010","journal-title":"BMC Biotechnol."},{"issue":"63","key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.09.049","article-title":"Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers.","volume":"146","author":"Ma","year":"2014","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0166-6851(98)00153-4","article-title":"Basis for substrate specificity of the Toxoplasma gondii nucleoside triphosphate hydrolase.","volume":"97","author":"Nakaar","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-3-540-72167-3_11","article-title":"Vaccination with messenger RNA (mRNA).","volume":"183","author":"Pascolo","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/mt.2010.289","article-title":"Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.","volume":"19","author":"Rittig","year":"2011","journal-title":"Mol. Ther."},{"key":"B31","first-page":"244","article-title":"Non-viral amplification systems for gene transfer: vectors based on alphaviruses.","volume":"1","author":"Smerdou","year":"1999","journal-title":"Curr. Opin. Mol. Ther."},{"key":"B32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.143.6.2045","article-title":"Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.","volume":"143","author":"Suzuki","year":"1989","journal-title":"J. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.vaccine.2011.01.089","article-title":"Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II.","volume":"29","author":"Tan","year":"2011","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.parint.2009.12.007","article-title":"Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii.","volume":"59","author":"Tan","year":"2010","journal-title":"Parasitol. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response.","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/IAI.68.1.38-45.2000","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.","volume":"68","author":"Vercammen","year":"2000","journal-title":"Infect. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/CJI.0b013e31815ce501","article-title":"Results of the first phase I\/II clinical vaccination trial with direct injection of mRNA.","volume":"31","author":"Weide","year":"2008","journal-title":"J. Immunother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/CJI.0b013e3181a00068","article-title":"Direct injection of protamine-protected mRNA: Results of a phase 1\/2 vaccination trial in metastatic melanoma patients.","volume":"32","author":"Weide","year":"2009","journal-title":"J. Immunother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erv.11.168","article-title":"mRNA vaccination as a safe approach for specific protection from type I allergy.","volume":"11","author":"Weiss","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","article-title":"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18.","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives.","volume":"12","author":"Zhang","year":"2013","journal-title":"Expert Rev. Vaccines"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.00605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:31:57Z","timestamp":1692750717000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.00605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":42,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.00605","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}